Factors associated with depression among Type-2 Diabetic Patients in Nepal

Authors

  • Ms. Priyanka MscPH, Kathmandu University School of Medical Sciences, Nepal
  • Mr. Prabin Institute of Medicine, Tribhuvan University
  • Ms. Yunika MscPH, Kathmandu University School of Medical Sciences, Nepal

DOI:

https://doi.org/10.62992/ijphap.v2i4.56

Keywords:

Type-2 Diabetes, Depression, Associated factors, Healthcare cost, Comorbidities

Abstract

Background: The worldwide health scenario is undergoing a shift from infectious diseases to non-communicable ones, and diabetes is now the seventh major contributor to global mortality. Depression, anticipated to be the second-highest contributor to Disability Adjusted Life Years by 2020, presents a notable public health challenge. The probability of experiencing depression is elevated two to three times in individuals with diabetes, particularly those diagnosed with Type 2 diabetes.

Objectives: To assess the prevalence of depression and associated factors in Type 2 diabetic patients in Tribhuvan University Teaching Hospital.

Methods: An analytical cross-sectional study was conducted among 151 Type 2 diabetic patients visiting Tribhuvan University Teaching Hospital, Nepal. Patients were selected by systematic random sampling at an interval of every third diabetic patient attending the Out-Patient Department. Depression was assessed using the Beck Depression Inventory. Data was analyzed using STATA-14 where logistic regression was performed to ascertain associations (P value <0.05) of sociodemographic, behavioral and clinical characteristics with depression.                       

Results: The prevalence of depression among Type 2 diabetic patients was 28.5%. Among them, 15.2% had mild depression, 11.9% had moderate depression and 1.4% had severe depression. The odds of having depression was 1.24 times higher with 1 unit increase in HbA1C level (AOR=1.24, 95%CI:1.09-1.42, P-value=0.001), 4.62 times higher in patients having retinopathy as comorbidity (AOR=4.62, 95%CI:1.63-13.11, P-value=0.04) and 6.36 times higher in patients taking insulin for treatment (AOR=6.36, 95%CI:1.79-22.53, P-value=0.004) after adjusting for age, sex, occupation, marital status, ethnicity income and education.

Conclusion:  The study revealed that more than a quarter of Type 2 diabetic patients in this sample experienced depression. Factors such as HbA1C, treatment by insulin and retinopathy as comorbidity were identified as significant contributors. These findings highlight the emerging problem of depression among diabetic patients, emphasizing the need for integrated mental health services in diabetes care.

References

Federation ID. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation; 2021.

Organization WH. Depression: let’s talk" says WHO, as depression tops list of causes of ill health Geneva, Switzerland: World Health Organization; 2017 [Available from: https://www.who.int/news/item/30-03-2017--depression-let-s-talk-says-who-as-depression-tops-list-of-causes-of-ill-health.

Federation ID. Diabetes in Nepal 2021: International Diabetes Federation; 2021 [cited 2024 March 19]. Available from: https://idf.org/our-network/regions-and-members/south-east-asia/members/nepal/.

Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes care. 2000;23(10):1556-62.

Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. Journal of affective disorders. 2012;142:S8-S21.

Roy T, Lloyd CE, Parvin M, Mohiuddin KGB, Rahman M. Prevalence of co-morbid depression in out-patients with type 2 diabetes mellitus in Bangladesh. BMC psychiatry. 2012;12:1-10.

Albasheer OB, Mahfouz MS, Solan Y, Khan DA, Muqri MA, Almutairi HA, et al. Depression and related risk factors among patients with type 2 diabetes mellitus, Jazan area, KSA: A cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(2):117-21.

Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Archives of internal medicine. 2000;160(21):3278-85.

Katon WJ. The comorbidity of diabetes mellitus and depression. The American journal of medicine. 2008;121(11):S8-S15.

Simon GE, Katon WJ, Lin EHB, Ludman E, VonKorff M, Ciechanowski P, et al. Diabetes complications and depression as predictors of health service costs. General hospital psychiatry. 2005;27(5):344-51.

Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes care. 2004;27(4):914-20.

Niraula K, Kohrt BA, Flora MS, Thapa N, Mumu SJ, Pathak R, et al. Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. BMC psychiatry. 2013;13:1-12.

Pahari DP, Upadhyay R, Sharma CK. Depression among diabetic patients visiting a diabetes center in Nepal. Health Prospect. 2018;17(1):21-5.

Pant SB, Ojha SP, Chapagai M, Tulachan P, Dhungana S. Depression and its association with glycemic control in Nepalese adults with diabetes mellitus. Journal of Institute of Medicine. 2016;40(1).

Karpha K, Biswas J, Nath S, Dhali A, Sarkhel S, Dhali GK. Factors affecting depression and anxiety in diabetic patients: a cross sectional study from a tertiary Care Hospital in Eastern India. Annals of Medicine and Surgery. 2022;84.

Sieu N, Katon W, Lin EHB, Russo J, Ludman E, Ciechanowski P. Depression and incident diabetic retinopathy: a prospective cohort study. General hospital psychiatry. 2011;33(5):429-35.

Downloads

Published

04-04-2024

Issue

Section

Original Article

Categories

How to Cite

1.
Factors associated with depression among Type-2 Diabetic Patients in Nepal. IJPHAP [Internet]. 2024 Apr. 4 [cited 2024 Oct. 4];2(4):52-65. Available from: https://ijphap.com/index.php/home/article/view/56